KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Dividends Paid - Common: 2018-2024

Historic Dividends Paid - Common for Royalty Pharma (RPRX) over the last 7 years, with Dec 2024 value amounting to $125.2 million.

  • Royalty Pharma's Dividends Paid - Common rose 10.52% to $34.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.2 million, marking a year-over-year increase of 33.81%. This contributed to the annual value of $125.2 million for FY2024, which is 4.71% up from last year.
  • Latest data reveals that Royalty Pharma reported Dividends Paid - Common of $125.2 million as of FY2024, which was up 4.71% from $119.5 million recorded in FY2023.
  • Royalty Pharma's Dividends Paid - Common's 5-year high stood at $144.1 million during FY2022, with a 5-year trough of $113.5 million in FY2020.
  • Its 3-year average for Dividends Paid - Common is $129.6 million, with a median of $125.2 million in 2024.
  • In the last 5 years, Royalty Pharma's Dividends Paid - Common declined by 26.35% in 2020 and then rose by 17.58% in 2021.
  • Royalty Pharma's Dividends Paid - Common (Yearly) stood at $113.5 million in 2020, then increased by 17.58% to $133.4 million in 2021, then climbed by 8.01% to $144.1 million in 2022, then decreased by 17.06% to $119.5 million in 2023, then rose by 4.71% to $125.2 million in 2024.